Investor Dossier
AdBio partners
active
Typeinvestor
Location—
Portfolio (8 investments)
RIBONEXUS
Seed · Sept 2021
LEAD
€4.0M
Thabor Therapeutics
Seed · Jan 2021
LEAD
—
Tridek-One
Series A · Sept 2022
LEAD
€16.0M
DiogenX
Series A · May 2023
€27.5M
Anoat Therapeutics
Seed · Jun 2023
LEAD
€2.0M
ASTRAVEUS
Seed · Jun 2023
LEAD
€16.7M
Calida Therapeutics
Seed · Apr 2023
LEAD
€2.0M
DiogenX
Series A · May 2023
LEAD
€34.0M